Hackers leaked MBA CET 2025-26 candidates' data, promising higher scores for a fee. Three were arrested after a police complaint from Eduspark.

While experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the drug used for the treatment of type 2 diabetes and obesity.

Pharma giant Eli Lilly has launched Mounjaro, a popular weight-loss drug, in India. Priced at Rs 3,500 for 2.5 mg and Rs 4,375 for 5 mg, Mounjaro is a ...

Chemically known as tirzepatide, Mounjaro is currently sold in the UK and Europe under the same brand name for both diabetes ...

By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

In recent years, Chinese micro-dramas have taken social media platforms by storm, captivating millions of viewers with their ...

The Karnataka High Court has quashed a hate speech case against CNN News18 consulting editor Rahul Shivshankar over his post ...

The Karnataka High Court has quashed a hate speech case against CNN News18 consulting editor Rahul Shivshankar over his post ...